English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The paper presents a continuation of discussion regarding personal matters on the course of inflammatory bowel diseases (IBD) such as ulcerative colitis (UC) and Crohn’s disease (KD) in pregnant women, including the problems of basic drug therapy of the main disease both during pregnancy and lactation period. Separately, there are data on safety of conducted therapy, indications for surgical treatment and use of biological genetically engeneered drugs. The paper is based on the materials of “The Second European Consensus on Reproduction and Pregnancy in Patients with Inflammatory Bowel Diseases, 2015”. The main positions are presented according to the criteria of evidence-based medicine.

permskij medicinskij žurnal

Inflammatory bowel diseases: course peculiarities and drug therapy in pregnant women. Lactation. Personal matters (by the materials of the second european consensus on reproduction and pregnancy in patients with inflammatory bowel diseases, 2015)